Animal Model: Bridging Biology and Behavior

For well over a century, the scientific investigation of human physiology, cognition, and psychopathology has relied on non-human living systems to decode the intricate mechanisms of life and disease. By serving as living surrogates in controlled experimental designs, an animal model enables scientists to investigate causal pathways, genetic perturbations, and novel pharmacological interventions that would be ethically and practically impossible to test directly in humans. From unraveling the fundamental architecture of neural circuits to testing lifesaving psychiatric and somatic therapies, the animal model remains an indispensable yet methodologically demanding pillar of translational biomedical science.

Animal Model

1. Concise Definition

An animal model is a non-human living organism utilized in biomedical, psychological, and behavioral research to investigate biological phenomena, disease processes, or behavioral archetypes under rigorously controlled conditions, with the explicit goal of extrapolating the findings to human biology and behavior. Such models serve as living functional proxies that mimic specific physiological, genetic, anatomical, or psychological characteristics of a target species, most frequently Homo sapiens.

Rather than providing an identical replica of human conditions, an animal model operates as an experimental analogue. It isolates specific operational variables—such as neuroreceptor dynamics, fear conditioning, cognitive decline, or stress reactivity—allowing researchers to establish directional causality between physiological substrates and phenotypic manifestations. The epistemic value of an animal model rests fundamentally on its translational fidelity, which is evaluated through empirical standards of face, construct, and predictive validity.

2. Etymology & Linguistic Origin

The term animal model represents a modern scientific compound derived from classical Latin roots. The word animal originates from the Latin noun animal, meaning "living being" or "creature possessing breath and life," which itself stems from anima, signifying "breath," "soul," or "vital principle." Historically, the term denoted any sentient creature capable of voluntary movement, distinct from plants and minerals.

The word model traces its ancestry to the Latin modellus, a diminutive of modulus, which translates to "measure," "standard," or "pattern." Through the Italian modello and Middle French modelle, the term entered the English language in the late sixteenth century to denote a structural representation, template, or design prototype. The modern scientific synthesis of animal model emerged prominently within twentieth-century physiology, comparative psychology, and experimental pharmacology to designate an organism functioning as a formalized, standardized experimental exemplar of human medical and behavioral phenomena.

3. Pronunciation & Grammatical Form

Pronunciation: /ˈæn.ɪ.məl ˈmɒd.əl/ (Received Pronunciation), /ˈæn.ə.məl ˈmɑː.dəl/ (General American).

Grammatical Form: Compound noun, countable. The plural form is animal models. It is frequently employed as an attributive nominal modifier, as seen in phrases such as animal model validation, animal model paradigms, and animal model translational pipelines.

4. Detailed Conceptual Explanation

The conceptual framework of an animal model is grounded in evolutionary biology and comparative physiology, which posit that fundamental biological mechanisms, cellular pathways, and behavioral adaptations are conserved across phylogenetic taxa. Because humans share substantial genetic homology, neural architecture, and endocrine signaling pathways with other vertebrates—particularly rodents and non-human primates—investigators can interrogate complex phenomena by isolating conserved subsystems within an evolutionarily related organism.

In experimental psychology and neuroscience, animal models do not merely emulate somatic pathologies; they operationalize affective, motivational, and cognitive states. A central challenge in modeling human psychopathology—such as major depressive disorder, generalized anxiety disorder, or schizophrenia—is that human psychiatric diagnoses rely extensively on subjective, verbal self-reports (such as feelings of worthlessness, existential despair, or auditory hallucinations). Non-human animals cannot report subjective experiences; consequently, researchers must deconstruct complex human syndromes into measurable endophenotypes and observable behavioral parameters. For instance, anhedonia is modeled via sucrose preference deficits, behavioral despair via mobility latency in a forced swim task, and working memory deficits via radial arm maze performance.

To evaluate the validity and scientific utility of an animal model, researchers rely on a triad of validation criteria first formalized in psychopharmacology by Paul Willner:

• Face Validity: The phenomenological similarity between the behavioral or physiological profile observed in the animal model and the clinical manifestations of the human condition (e.g., an animal displaying weight loss, sleep disruption, and reduced social interaction mirroring depressive symptomatology).
• Construct Validity: The degree of theoretical and mechanistic congruence between the model and the human disease. This requires that the underlying biological, neurochemical, or environmental etiology driving the animal phenotype authentically reflects the pathophysiology responsible for the disorder in humans.
• Predictive Validity: The capacity of the animal model to accurately forecast human clinical responses, most commonly demonstrated when therapeutic agents that ameliorate symptoms in humans produce analogous improvements in the model, while clinically ineffective compounds yield negative results.

The epistemological boundary of any animal model lies in its inevitable status as a reductionist representation. A model is never an exact identity; if it were biologically and structurally identical to the target in every respect, it would cease to be a model and become the entity itself. Therefore, researchers must delineate between homologous mechanisms (traits derived from a common evolutionary ancestor) and analogous mechanisms (traits that appear functionally similar due to convergent evolution or superficial adaptation but lack shared neurobiological pathways).

5. Historical Development

The systematic employment of non-human animals to deduce biological principles dates back to antiquity. Greek physician-philosophers such as Alcmaeon of Croton, Aristotle, and later Galen of Pergamon performed anatomical dissections and physiological vivisections on pigs, goats, and apes to infer human internal anatomy and circulatory principles, establishing the initial paradigm of the animal as an anatomical surrogate.

During the Scientific Revolution and the Enlightenment, non-human organisms transitioned from purely anatomical specimens into dynamic physiological systems. René Descartes conceptualized non-human animals as complex mechanical automata lacking immortal souls, a philosophical framing that historically legitimized invasive animal experimentation. In the nineteenth century, French physiologist Claude Bernard formalized the discipline of experimental medicine, arguing in his seminal 1865 treatise that physiological mechanisms could only be truly understood and therapeutically manipulated by systematic experimentation on living animals under controlled laboratory perturbations.

In the late nineteenth and early twentieth centuries, the domain of animal modeling expanded into psychology and behavioral neuroscience. Russian physiologist Ivan Pavlov uncovered the principles of classical conditioning by studying the salivary secretions of domestic dogs in response to conditioned sensory stimuli. Simultaneously, American comparative psychologists such as Edward Thorndike and B.F. Skinner developed formalized operant conditioning chambers (the "Skinner Box") utilizing pigeons and rodents, establishing quantitative behavioral models of reinforcement, associative learning, and habit formation.

The mid-to-late twentieth century witnessed the rise of dedicated psychiatric and neurobehavioral animal models. In the late 1960s, Martin Seligman and Steven Maier developed the paradigm of learned helplessness in canines and later rodents, providing a foundational behavioral model for human reactive depression and cognitive deficits. In the 1970s and 1980s, the advent of recombinant DNA technology and genetic engineering ushered in the modern molecular era. The creation of transgenic, knockout, and knock-in rodent strains enabled scientists to model specific human genetic lesions, transforming preclinical oncology, neurology, and neuropsychiatry into fields capable of cell-type-specific and gene-specific functional interrogation.

6. Theoretical Foundations

The primary theoretical foundation of animal modeling is Charles Darwin’s principle of evolutionary continuity, articulated in On the Origin of Species (1859) and expanded in The Expression of the Emotions in Man and Animals (1872). Darwin demonstrated that morphological, physiological, and emotional traits did not emerge de novo in humans; rather, they exist along a biological continuum shared with ancestral and contemporary species. This evolutionary homology establishes that fundamental cellular machinery, neurotransmitter signaling (e.g., dopamine, serotonin, glutamate, GABA), and ancient brain structures (e.g., the limbic system, brainstem, basal ganglia) operate with high preservation across vertebrate taxa.

A secondary theoretical foundation derives from general systems theory and cybernetics, which conceptualize organisms as self-regulating biological networks governed by homeostatic feedback loops. When exposed to exogenous perturbations—such as chronic restraint stress, chemical toxins, or surgical lesions—the animal model responds as an integrated biological system. This systemic response allows researchers to study complex organ-level and organism-level phenomena that cannot be adequately replicated in static cell cultures or computational simulations.

Within psychology, animal models are deeply rooted in behavioral genetics, neuroethology, and evolutionary psychopathology. Evolutionary psychopathology posits that psychiatric disorders frequently represent maladaptive dysregulations of ancient survival mechanisms, such as threat detection, social rank navigation, maternal attachment, and foraging optimization. By studying how non-human animals navigate predation threats, territorial aggression, or social isolation, behavioral scientists can reverse-engineer the neural and endocrine correlates of human anxiety, post-traumatic stress, and depressive withdrawal.

7. Key Components, Types & Dimensions

Animal models are broadly classified based on their underlying etiology, phenotypic presentation, and experimental manipulation:

• Homologous Models: Models that share both the fundamental biological etiology and the complete phenotypic symptom constellation with the human condition, representing the highest standard of translational validity (e.g., simian immunodeficiency virus in macaque monkeys modeling human HIV infection).
• Isomorphic Models: Models that replicate the visible symptoms, behavioral deficits, or physiological manifestations of a human disease but do not necessarily share the same underlying causes or genetic triggers.
• Predictive (Analogous) Models: Models that do not necessarily resemble the human disorder phenomenologically or mechanistically, yet reliably identify compounds or interventions that prove clinically effective in humans (e.g., screening antidepressant efficacy via latency alterations in the forced swim or tail suspension test).
• Genetic and Transgenic Models: Organisms whose genomes have been deliberately altered via homologous recombination, gene silencing, or gene editing (such as CRISPR-Cas9) to carry human pathogenic variants, gene deletions (knockouts), or gene insertions (knock-ins), widely utilized in modeling Huntington’s disease, Alzheimer’s disease, and autism spectrum disorders.
• Pharmacologically Induced Models: Paradigms where specific receptor agonists, antagonists, or neurotoxins are administered to induce transient or permanent neuropathological states (e.g., administering 6-hydroxydopamine or MPTP to destroy dopaminergic neurons, modeling Parkinson’s disease).
• Surgical and Lesion Models: Experimental paradigms in which specific brain structures, peripheral nerves, or somatic tissues are mechanically, chemically, or optogenetically disrupted to emulate focal trauma or neurodegeneration (e.g., middle cerebral artery occlusion to model ischemic stroke).
• Environmental and Stress-Induced Models: Experimental exposures that subject animals to naturalistic environmental, psychological, or social stressors, such as chronic unpredictable mild stress (CUMS), social defeat stress, or maternal separation paradigms.

8. Examples & Illustrative Cases

In behavioral neuroscience, one of the most widely employed paradigms is the Elevated Plus Maze (EPM), developed by Handley and Mithani and later validated by Pellow and colleagues. The apparatus consists of a cross-shaped platform elevated above the floor, featuring two open, unprotected arms and two enclosed, high-walled arms. The model leverages the innate rodent conflict between the exploratory drive to investigate a novel environment and an evolutionary aversion to open, bright, and elevated spaces (thigmotaxis). Rodents exhibiting heightened anxiety phenotypes spend significantly less time in the open arms, whereas those treated with anxiolytic drugs, such as benzodiazepines, exhibit marked increases in open-arm exploration. This assay exemplifies an isomorphic and predictive model of generalized anxiety states.

A major illustrative case in neuropsychiatry is the Chronic Social Defeat Stress (CSDS) paradigm. In this model, an experimental mouse is subjected to repeated bouts of physical subordination and social defeat by a larger, aggressive conspecific mouse, followed by prolonged sensory contact across a perforated transparent divider. Following multiple days of social defeat, a significant subset of the defeated mice develops enduring behavioral alterations: pronounced social avoidance, anhedonia (measured via reduced preference for sweetened water), metabolic disruptions, and neuroinflammatory remodeling in the ventral tegmental area and nucleus accumbens. Interestingly, a minority of mice display behavioral resilience, maintaining normal social interaction. This paradigm has provided vital mechanistic insights into the epigenetic and neurobiological substrates that differentiate psychiatric vulnerability from psychological resilience in humans exposed to chronic social stress.

In somatic and neurodegenerative medicine, the APP/PS1 transgenic mouse provides a primary example of genetic modeling. These mice carry mutated human genes encoding amyloid precursor protein (APP) and presenilin-1 (PSEN1), both linked to early-onset familial Alzheimer’s disease. As the mice age, they spontaneously develop extracellular beta-amyloid plaques in the hippocampus and cerebral cortex, accompanied by neuroinflammation, synaptic dysfunction, and severe progressive spatial learning deficits in the Morris water maze, offering a target for investigating anti-amyloid therapeutics and microglial clearance mechanisms.

9. Measurement & Assessment

Assessing an animal model requires the objective, quantitative operationalization of complex physiological and behavioral phenomena. Researchers employ sophisticated automated behavioral phenotyping systems, continuous telemetry, and neurochemical profiling to measure outcomes with high precision and minimal human bias.

Behavioral assessment relies on computer-vision software (such as EthoVision or DeepLabCut) capable of tracking animal kinematics, posture, velocity, path length, and spatial preferences across various arenas. Common operationalized tests include:

• Locomotor and Exploratory Activity: Evaluated using the Open Field Test, which measures total distance traversed, rearing frequency, and time spent in the periphery versus the center.
• Depressive-Like Endophenotypes: Assessed via the Sucrose Preference Test (measuring anhedonia) and the Forced Swim Test or Tail Suspension Test (measuring behavioral despair and immobility latencies).
• Cognitive Function and Spatial Memory: Quantified via the Morris Water Maze, the Barnes Maze, Novel Object Recognition (NOR), and T-maze or Y-maze spontaneous alternation tasks.
• Sensorimotor Gating: Measured using Prepulse Inhibition (PPI) of the acoustic startle reflex, an endophenotype widely used to study the neurobiological deficits of information filtering observed in schizophrenia.
• Addiction and Reinforcement: Evaluated via operant Intravenous Self-Administration (IVSA) and Conditioned Place Preference (CPP) paradigms, which quantify compulsive drug-seeking behavior and drug reward salience.

Simultaneously, researchers assess underlying physiological metrics by measuring baseline and stress-induced plasma corticosterone (the primary rodent glucocorticoid), tracking circadian body temperature and heart rate variability via surgically implanted telemetric transponders, conducting in vivo microdialysis to sample extracellular neurotransmitter concentrations, and utilizing fiber photometry or in vivo electrophysiology to record real-time neural ensemble firing during behavioral execution.

10. Applications & Practical Significance

The applications of animal models span basic, translational, and clinical domains. In translational neuroscience and psychopharmacology, animal models constitute an indispensable phase of the preclinical drug discovery pipeline. Before any novel chemical entity can be administered to human subjects in Phase I clinical trials, it must demonstrate safety, tolerability, target engagement, and therapeutic efficacy across rodent and non-rodent animal models as mandated by regulatory authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Beyond pharmacology, animal models serve as biological platforms for elucidating the precise causal relationships underlying human diseases. While human post-mortem brain studies and functional neuroimaging (fMRI) provide invaluable correlational data regarding disease states, they cannot cleanly disentangle cause from consequence. Through cell-type-specific optogenetics, chemogenetics (DREADDs), and targeted gene knockouts in rodent models, researchers can directly manipulate a discrete population of neurons—such as dopaminergic projections from the ventral tegmental area to the prefrontal cortex—and observe the immediate behavioral consequences, establishing unambiguous causal mechanisms.

In educational and developmental science, animal models have illuminated how adverse early-life experiences alter brain trajectory. Classic studies on maternal separation in rodents and non-human primates revealed how disrupted infant-caregiver bonding causes persistent hypersensitivity of the hypothalamic-pituitary-adrenal (HPA) axis, epigenetic modifications of glucocorticoid receptor genes, and structural pruning of prefrontal dendrites, directly informing human clinical interventions in developmental trauma and foster care policy.

11. Research & Empirical Evidence

Decades of empirical research demonstrate the predictive power of animal models in certain biomedical domains, accompanied by significant translational challenges in others. The validation of models for depression by Paul Willner in the 1980s and 1990s established standardized frameworks that directly aided the preclinical development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Classic studies by Eric Nestler, David Sweatt, and colleagues demonstrated that chronic stress in rodents triggers stable epigenetic alterations—including histone methylation and acetylation within the nucleus accumbens and hippocampus—empirically demonstrating that psychiatric vulnerability involves enduring alterations in chromatin architecture.

Similarly, foundational research in substance use disorders utilizing rodent self-administration paradigms, conducted by George Koob, Terry Robinson, and Kent Berridge, unraveled the dual mechanisms of reward sensitization and negative reinforcement (the "dark side" of addiction). Their work proved that drug dependence transitions from positive reinforcement mediated by ventral striatal dopamine to negative reinforcement driven by amygdalar corticotropin-releasing factor (CRF) and dynorphin activation, a paradigm shift that fundamentally transformed human clinical models of chemical dependency.

Conversely, significant empirical debate centers on the high rate of translational failure in neuropsychiatry, stroke, and oncology. Meta-analyses indicate that over 80% of neuroprotective compounds showing high efficacy in animal models of ischemic stroke subsequently failed to demonstrate therapeutic benefit in human Phase III clinical trials. Similarly, while hundreds of compounds alleviate behavioral immobility in the Forced Swim Test, a large proportion of these drugs fail as clinical antidepressants, illustrating that the assay primarily measures acute stress coping and behavioral passivity rather than complex, persistent depressive illness.

12. Cultural & Cross-Cultural Considerations

The utilization, societal acceptance, and ethical oversight of animal models vary considerably across different geographical, legal, and philosophical contexts. In Western scientific traditions, animal research is strictly governed by institutional, national, and international regulatory frameworks designed to protect animal welfare. The foundational ethical doctrine governing animal modeling worldwide is the principle of the "3Rs" (Replacement, Reduction, and Refinement), originally articulated by British zoologist William Russell and microbiologist Rex Burch in their 1959 treatise The Principles of Humane Experimental Technique (Russell and Burch’s 3Rs):

• Replacement: The continuous effort to substitute conscious living vertebrates with insentient material, such as cell cultures, organoids, or in silico computational models.
• Reduction: The application of advanced experimental design and statistical power calculations to minimize the number of animals required to obtain robust scientific data.
• Refinement: The implementation of surgical enhancements, environmental enrichment, non-invasive imaging, and analgesia to minimize potential pain, distress, or lasting harm experienced by the animals.

Legal systems reflect divergent regional priorities regarding animal experimentation. The European Union operates under some of the most rigorous welfare statutes globally, codified in Directive 2010/63/EU, which strictly limits the use of non-human primates, bans the use of great apes in biomedical research, and mandates transparent public non-technical summaries of all animal studies. In the United States, research is governed under the Animal Welfare Act (AWA) and the Public Health Service (PHS) Policy, enforced by Institutional Animal Care and Use Committees (IACUCs); notably, however, the federal AWA excludes laboratory-bred rats, mice, and birds from its formal oversight definitions, although institutions receiving federal funding (such as NIH grants) must maintain high accreditation standards regardless of species.

Cultural and philosophical perspectives on the moral status of non-human animals also influence scientific practice. Western views have historically been shaped by Cartesian anthropocentrism, which viewed animals through an instrumental lens. In contrast, philosophical and religious traditions originating in the East—such as Buddhism, Hinduism, and Jainism—are underpinned by the concept of Ahimsa (non-violence) and the belief in the transmigration of souls (reincarnation), granting non-human animals profound moral consideration. These contrasting cultural attitudes increasingly inform global biomedical ethics, demanding greater justification, accountability, and compassionate stewardship in experimental research.

13. Criticisms, Debates & Limitations

The field of animal modeling faces major scientific, methodological, and ethical debates. The primary scientific criticism involves the "translational crisis" or "translational chasm"—the high rate of failure when transitioning drug candidates from successful preclinical animal studies to human clinical efficacy. Critics argue that evolutionary divergence across tens of millions of years has produced substantial discrepancies in metabolic pathways, blood-brain barrier permeability, receptor expression, and genomic responses between humans and rodents. For example, genomic analyses have demonstrated that inflammatory responses in mouse models correlate poorly with human clinical inflammatory conditions such as sepsis, burns, and severe trauma.

Another central methodological limitation is the standard laboratory environment. Laboratory rodents are typically housed in sterile, barren, temperature-controlled polypropylene cages with limited social and cognitive stimulation. Behavioral neuroscientists have highlighted that standard laboratory rodents represent an atypical, sedentary, and metabolically dysfunctional population—sometimes termed "couch potato" animals. This lack of ecological validity may alter neural development, neurogenesis, and immune function, producing experimental phenotypes that fail to withstand the complex, variable environments encountered by humans.

Epistemologically, anthropomorphism remains a constant concern in psychiatric animal modeling. Interpreting an animal’s reduction in movement during an inescapable water tank test as "despair" or "hopelessness" can represent an anthropomorphic over-interpretation of what may simply be an adaptive energy-conservation strategy. Conversely, Frans de Waal warned against "anthropodenial"—the dogmatic refusal to acknowledge that non-human animals share basic emotional, cognitive, and social capacities with humans.

Finally, bioethicists and animal welfare advocates argue that the severe suffering inflicted in models of psychiatric distress, traumatic brain injury, chronic pain, and addiction cannot be morally justified by uncertain translational benefits. This controversy has accelerated the development of non-animal alternatives, including induced pluripotent stem cell (iPSC)-derived human cerebral organoids, microfluidic "organ-on-a-chip" platforms, and high-performance in silico machine learning simulations.

14. Related Terms & Distinctions

To accurately understand the scope of animal models, it is essential to distinguish them from related scientific concepts and alternatives:

• In Vitro Models: Experimental systems utilizing isolated cellular cultures, tissue slices, or subcellular fractions in artificial environments outside of a living organism. Unlike animal models, in vitro systems lack full physiological feedback loops, systemic endocrine networks, and behavioral outputs.
• In Silico Models: Computational simulations, mathematical algorithms, and machine learning models that simulate biological systems or predict chemical-receptor binding. They serve as valuable screening tools to refine and reduce animal usage, though they remain dependent on empirically derived biological training data.
• Human Organoids ("Organs-on-a-Chip"): Three-dimensional, stem-cell-derived micro-tissues that recapitulate the cellular heterogeneity and architecture of human organs (such as cerebral organoids). While they offer human-specific genetic environments, they currently lack vascularization, immune system integration, and behavioral correlates.
• Comparative Psychology: The academic discipline dedicated to studying the behavior and mental processes of diverse non-human animals for their own intrinsic evolutionary interest, whereas animal modeling explicitly uses animals as translational proxies to understand human biology and pathology.
• Ethology: The scientific study of animal behavior in natural environments, focusing on instinctual patterns and evolutionary fitness, contrasting with the strictly manipulated, artificial contexts characteristic of laboratory animal models.
• Phenocopy: An environmentally induced phenotype that mimics the physical or behavioral manifestations of a specific genetic condition, often created within animal models via targeted chemical or surgical perturbations.

15. Summary / Key Takeaways

• An animal model is a non-human living organism used to investigate biological, psychological, or pathological processes to extrapolate findings to human health and disease.
• The scientific validity of an animal model is evaluated across three primary dimensions: face validity (phenomenological similarity), construct validity (mechanistic and etiological accuracy), and predictive validity (pharmacological and therapeutic concordance).
• Models range in design from genetic, transgenic, and pharmacological paradigms to complex behavioral and stress-induction assays.
• Animal models provide unique experimental advantages by enabling causal mechanistic manipulation, genetic modification, and preclinical drug screening that cannot be conducted in humans.
• Major limitations include the translational crisis (discrepancy between preclinical and clinical outcomes), the artificial nature of standard laboratory housing, evolutionary divergences in physiology, and critical ethical concerns regarding animal sentience and suffering.
• The international research community navigates these limitations through the 3Rs framework (Replacement, Reduction, and Refinement), continually striving to advance both animal welfare and human translational relevance.

Ultimately, the animal model represents both an extraordinary scientific asset and a profound ethical responsibility. While living proxies have unlocked the basic neurochemistry of emotion, cognition, and neurodegeneration, their continued implementation demands rigorous methodological refinement, critical cross-species validation, and a sustained commitment to replacing live subjects with cutting-edge alternative technologies whenever scientifically feasible.

References

• Bernard, C. (1865). An introduction to the study of experimental medicine. Henry Schuman.
• Darwin, C. (1872). The expression of the emotions in man and animals. John Murray.
• Nestler, E. J., & Hyman, S. E. (2010). Animal models of neuropsychiatric disorders. Nature Neuroscience, 13(10), 1161–1169. https://doi.org/10.1038/nn.2647
• Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14(3), 149–167. https://doi.org/10.1016/0165-0270(85)90031-7
• Russell, W. M. S., & Burch, R. L. (1959). The principles of humane experimental technique. Methuen & Co.
• Seligman, M. E., & Maier, S. F. (1967). Failure to escape traumatic shock. Journal of Experimental Psychology, 74(1), 1–9. https://doi.org/10.1037/h0024514
• Willner, P. (1984). The validity of animal models of depression. Psychopharmacology, 83(1), 1–16. https://doi.org/10.1007/BF00427414